Patient assistance programs provide relief throughout the entire patient journey An advocate with every step The situation Over 20 years ago, Dennis Rinaldi was diagnosed with Essential Thrombo- cythemia, an uncommon disorder in which one’s bone marrow produces too many platelets, the part of blood that sticks together to form clots. 1 In 2010, Dennis participated in a four-year study to try a new treatment using pegylated interferon, or peginterferon. When the trial ended, the doctors sup- plied Dennis with a three-month supply of the medication as a thank-you for his participation. But when he started to run out, at age 62, Dennis knew the price of the medication exceeded his retirement income. A 48-week supply of interferon could cost upwards of $40,000. Dennis applied for t

Join for free to read